Macquarie Group’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,637
Closed -$139K 2068
2022
Q3
$139K Sell
2,637
-93
-3% -$3.6K ﹤0.01% 1684
2022
Q2
$88K Hold
2,730
﹤0.01% 1898
2022
Q1
$90 Hold
2,730
﹤0.01% 1982
2021
Q4
$116K Sell
2,730
-633
-19% -$26.5K ﹤0.01% 1888
2021
Q3
$149K Buy
3,363
+1,685
+100% +$77.3K ﹤0.01% 1860
2021
Q2
$95K Sell
1,678
-22
-1% -$1.55K ﹤0.01% 1986
2021
Q1
$127K Sell
1,700
-547
-24% -$44.8K ﹤0.01% 1835
2020
Q4
$194K Hold
2,247
﹤0.01% 1672
2020
Q3
$137K Hold
2,247
﹤0.01% 1704
2020
Q2
$93K Buy
2,247
+547
+32% +$19.9K ﹤0.01% 1774
2020
Q1
$49K Sell
1,700
-21,041
-93% -$1.22M ﹤0.01% 1819
2019
Q4
$1.64M Hold
22,741
﹤0.01% 1095
2019
Q3
$3.19M Hold
22,741
0.01% 882
2019
Q2
$4.16M Buy
22,741
+4,169
+22% +$711K 0.01% 822
2019
Q1
$2.95M Sell
18,572
-220
-1% -$31.9K 0.01% 893
2018
Q4
$1.8M Buy
18,792
+5,995
+47% +$686K ﹤0.01% 988
2018
Q3
$1.81M Sell
12,797
-703
-5% -$109K ﹤0.01% 1033
2018
Q2
$2.11M Buy
13,500
+10,676
+378% +$1.68M ﹤0.01% 986
2018
Q1
$455K Buy
+2,824
New +$479K ﹤0.01% 1419

Other funds holding SAGE